Graf Akcie MEIP (MEI Pharma Inc). Diskuze k akciím MEIP. Aktuální informace MEIP.

Základní informace o společnosti MEI Pharma Inc (Akcie MEIP)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 334.21M
Hodnota podniku (EV) 158.69M
Tržby 25.535M
EBITDA -69.40
Zisk -50.58
Růst v tržbách Q/Q -60.34 %
Růst v tržbách Y/Y -11.68 %
P/E (Cena vůči ziskům) N/A
Forward P/E 0.04
EV/Sales 6.21
EV/EBITDA N/A
EV/EBIT N/A
PEG 28.70
Price/Sales 12.96
P/FCF N/A
Price/Book 8.00
Účetní hodnota na akcii 0.37
Hotovost na akcii 1.38
FCF vůči ceně -9.88 %
Počet zaměstnanců 51
Tržba na zaměstnance 500.686k
Profit margin -198.06 %
Operating margin -272.90 %
Gross margin 94.49 %
EBIT margin -198.03 %
EBITDA margin -271.78 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst -73.68 %
EPS - Očekávaný růst příští rok 550.00 %
Return on assets -26.00 %
Return on equity -83.54 %
ROIC -26.35 %
ROCE -35.16 %
Dluhy/Equity 3.21
Čistý dluh/EBITDA 9.22
Current ratio 5.44
Quick Ratio 5.44
Volatilita 5.02
Beta 1.11
RSI 55.55
Cílová cena analytiků 9
Známka akcie (dle analytiků) 1.00
Insider ownership 2.84 %
Institutional ownership 74.16 %
Počet akcií 112.678M
Procento shortovaných akcií 10.20 %
Short ratio 24.47 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2004
Země United States

Finanční výsledky akcie MEIP

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$28.913$4.915$1.622$23.249--
Cost Of Goods Sold$2.671$4.263$3.383$5--
Gross Profit$26.242$0.652$-1.761$18.249--
Research And Development Expenses$34.065$32.3$17.038$7.237$13.403$23.823
SG&A Expenses$16.717$14.597$9.787$8.628$7.601$8.948
Other Operating Income Or Expenses------
Operating Expenses$53.453$51.16$30.208$20.865$21.004$32.771
Operating Income$-24.54$-46.245$-28.586$2.384$-21.004$-32.771
Total Non-Operating Income/Expense$-21.475$29.427$-11.481$0.287$0.143$0.078
Pre-Tax Income$-46.015$-16.818$-40.067$2.671$-20.861$-32.693
Income Taxes$-0.001$-0.001$-0.001$-0.001$-0.001$-0.001
Income After Taxes$-46.014$-16.817$-40.066$2.672$-20.86$-32.692
Other Income------
Income From Continuous Operations$-46.014$-16.817$-40.066$2.672$-20.86$-32.692
Income From Discontinued Operations------
Net Income$-46.016$-16.819$-40.068$2.67$-20.862$-32.694
EBITDA$-24.204$-46.165$-28.533$2.469$-20.946$-32.707
EBIT$-24.54$-46.245$-28.586$2.384$-21.004$-32.771
Basic Shares Outstanding917141373428
Shares Outstanding917241373428
Basic EPS$-0.51$-0.24$-0.97$0.07$-0.61$-1.16
EPS - Earnings Per Share$-0.51$-0.75$-0.97$0.07$-0.61$-1.16
# 2020 2019 2018 2017 2016 2015
Current Ratio8.95315.747713.231311.36938.481312.9625
Long-term Debt / Capital------
Debt/Equity Ratio------
Gross Margin90.761913.2655-108.569778.4937--
Operating Margin-84.8753-940.8952-1762.39210.2542--
EBIT Margin-84.8753-940.8952-1762.39210.2542--
EBITDA Margin-83.7132-939.2675-1759.12510.6198--
Pre-Tax Profit Margin-159.1499-342.177-2470.22211.4887--
Net Profit Margin-159.1533-342.1974-2470.28411.4844--
Asset Turnover0.13790.05950.01550.4174--
Inventory Turnover Ratio------
Receiveable Turnover1.41590.9319----
Days Sales In Receivables257.7837391.6602----
ROE - Return On Equity-58.8279-35.0866-79.40315.2559-50.0816-54.6771
Return On Tangible Equity-58.8279-35.2787-79.87165.2904-50.5256-55.0463
ROA - Return On Assets-21.9399-20.3441-38.28324.7968-44.2287-50.4896
ROI - Return On Investment-58.8279-35.0866-79.40315.2559-50.0816-54.6771
Book Value Per Share0.70140.65170.71671.38251.21951.7505
Operating Cash Flow Per Share0.78260.1012-0.60210.61350.4761-0.0256
Free Cash Flow Per Share0.77580.0982-0.60070.61220.4765-0.0236